| Patents for C07C 317 - Sulfones; Sulfoxides (15,874) |
|---|
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1303064C Novel colour former and recording material |
| 03/07/2007 | CN1303063C Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient |
| 03/06/2007 | US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 03/06/2007 | US7186860 Esterification of 2-[(diphenylmethyl)thio]acetic acid with an acyclic alcohol under reflux in the presence of an acid catalyst; amidation with ammonia; further oxidation with hydrogen peroxide produces Modafinil; central nervous system stimulant; narcolepsy |
| 03/06/2007 | US7186854 Use of p- fluorobenzenesulfinic acid salt as a reagent |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186414 Improved bioavailability; for oral and intracolonic administration |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 02/28/2007 | EP1756062A1 Compounds and compositions as ppar modulators |
| 02/28/2007 | EP1756025A1 Sulfonamide derivatives |
| 02/28/2007 | EP1233013B1 Novel phenylalanine derivatives |
| 02/28/2007 | CN1302030C Non-crystalline tetrafuoro ethylene-hexafuoro propene copolymer |
| 02/28/2007 | CN1301974C Muller Klaus-helmut |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/22/2007 | WO2007020381A2 Process for the synthesis of mandipropamid and derivatives thereof |
| 02/22/2007 | WO2006108695A3 Sulfoximine-pyrimidine macrocycles and the salts thereof , a process for making them, and their pharmaceutical use against cancer |
| 02/22/2007 | WO2005089511A3 Novel pharmaceutical forms, and methods of making and using the same |
| 02/22/2007 | US20070043011 Substituted benzanilide compound and noxious organism controlling agent |
| 02/22/2007 | US20070042996 N-alkynyl-2-(substituted aryloxy) alkylthioamine derivatives as fungicides |
| 02/22/2007 | CA2619435A1 Process for the synthesis of mandipropamid and derivatives thereof |
| 02/21/2007 | EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 02/21/2007 | EP1753714A2 2-substituted and 4-substituted aryl nitrone compouds |
| 02/21/2007 | EP1551798B1 Novel sulphones for inhibition of gamma secretase |
| 02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 02/21/2007 | EP1392281B1 Anti-endoparasitic amidoacetonitrils |
| 02/21/2007 | CN1918106A Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid |
| 02/21/2007 | CN1917870A Compounds and compositions as lxr modulators |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
| 02/15/2007 | US20070037990 Method of producing an organic compound comprising at least one oxygenated functional group |
| 02/15/2007 | US20070037812 Such as 3-{4-[3-(4-Chloro-2- phenoxy-phenoxy)- phenoxy]-2-methyl- phenyl}-propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis |
| 02/15/2007 | US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 02/14/2007 | EP1501792B1 Catalytic process for preparing perfluoroethanesulfonyl fluoride and/or perfluorodiethylsulfone |
| 02/14/2007 | EP0946478B1 Process for the solid phase synthesis of aldehydes, ketones and hydroxamic acid compounds |
| 02/14/2007 | CN1914169A Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
| 02/14/2007 | CN1914151A Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
| 02/14/2007 | CN1914149A Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events |
| 02/14/2007 | CN1911909A Processes for the preparation of diphenylsulfone compounds |
| 02/14/2007 | CN1911908A Processes for the preparation of diphenylsulfone compounds |
| 02/14/2007 | CN1299777C Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase |
| 02/13/2007 | CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 02/08/2007 | US20070032455 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 02/07/2007 | EP1748979A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
| 02/07/2007 | CN1907965A Toluenesulfonamide derivative and insecticidal activity thereof |
| 02/07/2007 | CN1907949A Calcium receptor-active compounds |
| 02/06/2007 | US7173052 Resorcinol for lightening skin removing color |
| 02/06/2007 | CA2192594C Preparation of .alpha.-methoxyiminocarboxylic acid methylamides and intermediates therfore |
| 02/01/2007 | WO2007012183A1 Process for the production of bicalutamide |
| 02/01/2007 | WO2006138508A3 Benzamide derivatives and uses related thereto |
| 01/31/2007 | EP1748046A2 Inhibitors of histone deacetylase |
| 01/31/2007 | CN1906158A Method for producing 2-halogenated benzamides |
| 01/31/2007 | CN1297543C Substitued arylketones |
| 01/30/2007 | US7169955 Perfluoroisopropylbenzene derivative |
| 01/30/2007 | US7169950 Reacting ozone with unsaturated compound |
| 01/30/2007 | US7169809 Reducing risk of thrombotic cardiovascular events such as stroke, myocardial ischemia, myocardial infarction, angina pectoris, and transient ischemic attack; side effect reduction |
| 01/30/2007 | US7169737 Phenolic compound and recording material using the same |
| 01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 01/30/2007 | CA2144133C Monomers derived from perhalogenated sultones and polymers produced from said monomers |
| 01/26/2007 | CA2513356A1 Process for production of bicalutamide |
| 01/25/2007 | WO2007010387A2 Stereoselective synthesis of 3,4-disubstituted cyclopentanones and related compounds |
| 01/25/2007 | WO2007009250A1 Renin inhibitors |
| 01/25/2007 | US20070021472 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility |
| 01/25/2007 | CA2615490A1 Stereoselective synthesis of 3,4-disubstituted cyclopentanones and related compounds |
| 01/25/2007 | CA2615048A1 Renin inhibitors |
| 01/24/2007 | EP1745787A2 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1-alpha 25-dihydroxy Vitamin D3 |
| 01/24/2007 | EP1745015A1 Bicyclic aromatic sulfinyl derivatives |
| 01/24/2007 | EP1744747A2 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity |
| 01/24/2007 | CN1902159A Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 01/24/2007 | CN1296331C Method of deuterating aromatic ring |
| 01/23/2007 | US7166738 viricides; polymerase inhibitors; therapy for genetic engineered virus |
| 01/23/2007 | US7166648 Containing a beta-diketone or a beta -ketoester; for example 3-{4-Acetyl-4-[2-(ethoxycarbonyl)ethyl]-5-oxohexanoyloxy}-2,2-dimethylpropyl ethyl 4,4-diacetylheptane-1,7-dioate; use in photocuring of UV curable ethylenically unsaturated compounds; yields colorless products; nonyellowing |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |
| 01/23/2007 | CA2273156C Novel 2-fluoroacrylic acid derivatives, novel mixtures of herbicides and antidotes and their use |
| 01/23/2007 | CA2101104C Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumors |
| 01/18/2007 | WO2006124875A3 Diarylsulfone sulfonamides and use therof |
| 01/18/2007 | US20070015918 Derivatives of 1,3-diones having a herbicidal activity |
| 01/18/2007 | US20070015870 Sulfoxides or sulfones grafted onto polymers |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015745 e.g. 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; antidiabetic agent, obesity |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1742908A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/17/2007 | EP1742906A2 Non-linear optically active molecules, their synthesis, and use |
| 01/17/2007 | EP1379497B1 Derivatives of benzoylcyclohexanedione and their use as herbicides |
| 01/17/2007 | EP1363878B1 Process for preparing sulfamoyl-substituted phenethylamine derivatives |
| 01/17/2007 | EP1309547B1 Crystalline and pure modafinil, and process of preparing the same |
| 01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 01/17/2007 | CN1897911A Merocyanine derivatives for cosmetic use |
| 01/17/2007 | CN1295213C Fluorinated cycloalkyl-derivatized benzoylguanidines and their uses as medicament |
| 01/16/2007 | US7163988 Aromatic sulfonic acid ester derivative, polyarylene, polyarylene having sulfonic acid group and process for producing the same, and polymer solid electrolyte and proton-conductive membrane |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/11/2007 | WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/11/2007 | WO2005079270A3 2-substituted and 4-substituted aryl nitrone compouds |
| 01/11/2007 | US20070010422 Improved bioavailability; for oral and intracolonic administration |